Old S E, Sato S, Kador P F, Carper D A
National Eye Institute, National Institutes of Health, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 1990 Jul;87(13):4942-5. doi: 10.1073/pnas.87.13.4942.
Aldose reductase (alditol:NADP+ oxidoreductase, EC 1.1.1.21), an enzyme that converts glucose to sorbitol, the first step of the polyol pathway, has been implicated in secondary complications of diabetes, such as cataracts, retinopathy, neuropathy, and nephropathy. Aldose reductase inhibitors have been observed to prevent or delay the onset of these complications; however, more potent and specific inhibitors are needed. Development of new inhibitors necessitates a better understanding of the molecular structure of this protein. To elucidate the structure-function relationships of aldose reductase and to develop methods of regulating this enzyme, large and homogeneous quantities of rat lens aldose reductase have been expressed in bacterial cells. A construction of the complete coding sequence and 3' untranslated region for rat lens aldose reductase was assembled in the expression vector pKK233-2 (Pharmacia). This construction expresses an active enzyme that has been purified and demonstrates kinetic, immunological, and inhibitory properties similar to rat lens aldose reductase.
醛糖还原酶(醛糖醇:NADP⁺氧化还原酶,EC 1.1.1.21),一种将葡萄糖转化为山梨醇的酶,这是多元醇途径的第一步,已被认为与糖尿病的继发性并发症有关,如白内障、视网膜病变、神经病变和肾病。已观察到醛糖还原酶抑制剂可预防或延缓这些并发症的发生;然而,需要更有效和特异的抑制剂。开发新的抑制剂需要更好地了解该蛋白质的分子结构。为了阐明醛糖还原酶的结构 - 功能关系并开发调节该酶的方法,已在细菌细胞中表达了大量且均一的大鼠晶状体醛糖还原酶。大鼠晶状体醛糖还原酶的完整编码序列和3'非翻译区构建体被组装到表达载体pKK233 - 2(Pharmacia)中。该构建体表达一种已被纯化的活性酶,其表现出与大鼠晶状体醛糖还原酶相似的动力学、免疫学和抑制特性。